Philip K. Yachmetz, EVP, Chief Business Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 10,000 shares at $23.02 ($231K) on 2008-01-07, disclosed to the SEC on 2008-01-09.
Open-market sale of $231k SVNT by EVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.02 | 5,000 | $115K | 49.9% |
| 2 | $23.15 | 5,000 | $116K | 50.1% |
| Total | $23.09 avg | 10,000 | $231K | 100% |
| Filing → |
| SVNT | SELL | 2013-01-16 | $1K | — | Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |